MedPath

ALYMSYS

ALYMSYS (bevacizumab-maly) is biosimilar* to AVASTIN (bevacizumab)

Approved
Approval ID

6b4040a2-a5c5-4ff0-ab45-935d7e49cf78

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 23, 2022

Manufacturers
FDA

Amneal Pharmaceuticals LLC

DUNS: 827748190

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

bevacizumab-maly

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70121-1755
Application NumberBLA761231
Product Classification
M
Marketing Category
C73585
G
Generic Name
bevacizumab-maly
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 23, 2022
FDA Product Classification

INGREDIENTS (6)

TREHALOSE DIHYDRATEInactive
Quantity: 960 mg in 16 mL
Code: 7YIN7J07X4
Classification: IACT
POLYSORBATE 20Inactive
Quantity: 6.4 mg in 16 mL
Code: 7T1F30V5YH
Classification: IACT
BEVACIZUMABActive
Quantity: 400 mg in 16 mL
Code: 2S9ZZM9Q9V
Classification: ACTIB
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Quantity: 19.2 mg in 16 mL
Code: 22ADO53M6F
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Quantity: 92.8 mg in 16 mL
Code: 593YOG76RN
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

bevacizumab-maly

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70121-1754
Application NumberBLA761231
Product Classification
M
Marketing Category
C73585
G
Generic Name
bevacizumab-maly
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 23, 2022
FDA Product Classification

INGREDIENTS (6)

BEVACIZUMABActive
Quantity: 100 mg in 4 mL
Code: 2S9ZZM9Q9V
Classification: ACTIB
TREHALOSE DIHYDRATEInactive
Quantity: 240 mg in 4 mL
Code: 7YIN7J07X4
Classification: IACT
POLYSORBATE 20Inactive
Quantity: 1.6 mg in 4 mL
Code: 7T1F30V5YH
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Quantity: 4.8 mg in 4 mL
Code: 22ADO53M6F
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Quantity: 23.2 mg in 4 mL
Code: 593YOG76RN
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ALYMSYS - FDA Drug Approval Details